These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24557413)

  • 41. Highly-integrated lab-on-chip system for point-of-care multiparameter analysis.
    Schumacher S; Nestler J; Otto T; Wegener M; Ehrentreich-Förster E; Michel D; Wunderlich K; Palzer S; Sohn K; Weber A; Burgard M; Grzesiak A; Teichert A; Brandenburg A; Koger B; Albers J; Nebling E; Bier FF
    Lab Chip; 2012 Feb; 12(3):464-73. PubMed ID: 22038328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological cells on microchips: new technologies and applications.
    Tanaka Y; Sato K; Shimizu T; Yamato M; Okano T; Kitamori T
    Biosens Bioelectron; 2007 Nov; 23(4):449-58. PubMed ID: 17881213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering transfer of micro- and nanometer-scale features by surface energy modification.
    Cortese B; Piliego C; Viola I; D'Amone S; Cingolani R; Gigli G
    Langmuir; 2009 Jun; 25(12):7025-31. PubMed ID: 19405480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microfluidic devices for bioapplications.
    Yeo LY; Chang HC; Chan PP; Friend JR
    Small; 2011 Jan; 7(1):12-48. PubMed ID: 21072867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review of cell and particle trapping in microfluidic systems.
    Nilsson J; Evander M; Hammarström B; Laurell T
    Anal Chim Acta; 2009 Sep; 649(2):141-57. PubMed ID: 19699390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microfluidic serial dilution ladder.
    Ahrar S; Hwang M; Duncan PN; Hui EE
    Analyst; 2014 Jan; 139(1):187-90. PubMed ID: 24231765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The evolving field of induced pluripotency: recent progress and future challenges.
    Sommer CA; Mostoslavsky G
    J Cell Physiol; 2013 Feb; 228(2):267-75. PubMed ID: 22767332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetic regulation of telomere chromatin integrity in pluripotent embryonic stem cells.
    Wong LH
    Epigenomics; 2010 Oct; 2(5):639-55. PubMed ID: 22122049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constructing stem cell microenvironments using bioengineering approaches.
    Brafman DA
    Physiol Genomics; 2013 Dec; 45(23):1123-35. PubMed ID: 24064536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Industrial lab-on-a-chip: design, applications and scale-up for drug discovery and delivery.
    Vladisavljević GT; Khalid N; Neves MA; Kuroiwa T; Nakajima M; Uemura K; Ichikawa S; Kobayashi I
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1626-63. PubMed ID: 23899864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fabrication of biofunctionalized microfluidic structures by low-temperature wax bonding.
    Díaz-González M; Baldi A
    Anal Chem; 2012 Sep; 84(18):7838-44. PubMed ID: 22905798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in microfluidics for drug discovery.
    Lombardi D; Dittrich PS
    Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lab-on-a-chip: microfluidics in drug discovery.
    Dittrich PS; Manz A
    Nat Rev Drug Discov; 2006 Mar; 5(3):210-8. PubMed ID: 16518374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microfluidic approaches for cancer cell detection, characterization, and separation.
    Chen J; Li J; Sun Y
    Lab Chip; 2012 Apr; 12(10):1753-67. PubMed ID: 22437479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic dedifferentiation of somatic cells into pluripotency: cellular alchemy in the age of regenerative medicine?
    Oliveri RS
    Regen Med; 2007 Sep; 2(5):795-816. PubMed ID: 17907932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Research highlights: micro-engineered therapies.
    Kong JE; Kahkeshani S; Pushkarsky I; Di Carlo D
    Lab Chip; 2014 Dec; 14(24):4585-9. PubMed ID: 25353397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-dependent cell-based assays in V-shaped microfluidic channels.
    Li CW; Yang J; Yang M
    Lab Chip; 2006 Jul; 6(7):921-9. PubMed ID: 16804597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combinations of regenerative medicine and Lab-on-a-chip systems: New hope to restoring the proper function of pancreatic islets in diabetes.
    Sokolowska P; Janikiewicz J; Jastrzebska E; Brzozka Z; Dobrzyn A
    Biosens Bioelectron; 2020 Nov; 167():112451. PubMed ID: 32777682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of microfabrication and hydrogel engineering for micro-organs on chips.
    Verhulsel M; Vignes M; Descroix S; Malaquin L; Vignjevic DM; Viovy JL
    Biomaterials; 2014 Feb; 35(6):1816-32. PubMed ID: 24314552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.